These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5758165)

  • 1. [Experimental and clinical study of a new non-steroid anti-inflammatory agent: butoxyphenylacethydroxamic acid (Droxaryl)].
    Van Cauwenberge H; Franchimont P
    J Belge Rhumatol Med Phys; 1968; 23(3):133-48. PubMed ID: 5758165
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental and clinical study of a new non-steroidal anti-inflammatory agent: butoxyphenylacetylhydroxamic acid (Droxaryl)].
    Van Cauwenberge H
    Rev Rhum Mal Osteoartic; 1967 Sep; 34(9):480-8. PubMed ID: 4384373
    [No Abstract]   [Full Text] [Related]  

  • 3. [1st considerations on the therapeutic contribution of p-butoxyphenylacethydroxamic acid (Droxaryl) in physical medicine].
    Paque GR
    J Belge Rhumatol Med Phys; 1969; 24(6):273-8. PubMed ID: 5403085
    [No Abstract]   [Full Text] [Related]  

  • 4. [p-butoxyphenylacethydroxamic acid in the treatment of rheumatic diseases].
    Viara M
    Clin Ter; 1974 Jul; 70(2):153-60. PubMed ID: 4408408
    [No Abstract]   [Full Text] [Related]  

  • 5. [A new non-steroid anti-inflammatory agent in therapy of osteoarthrosis].
    Loizzi P
    Clin Ter; 1980 Mar; 92(5):497-512. PubMed ID: 7004750
    [No Abstract]   [Full Text] [Related]  

  • 6. [Preliminary study of the action of p-butoxyphenylacethydroxamic acid (Bufexamac) in the treatment of coxarthrosis].
    Bloch-Michel H; Parrot M
    Therapie; 1970; 25(5):969-75. PubMed ID: 5486155
    [No Abstract]   [Full Text] [Related]  

  • 7. [P-butoxyphenylacethydroxamic acid in analgesic and anti-inflammatory therapy].
    Rosoux E
    Brux Med; 1969 Jul; 49(7):467-9. PubMed ID: 5402954
    [No Abstract]   [Full Text] [Related]  

  • 8. [Droxaryl, a new non-steroid anti-inflammatory agent].
    Suţeanu S
    Med Interna (Bucur); 1969 Jan; 21(1):119-21. PubMed ID: 5305051
    [No Abstract]   [Full Text] [Related]  

  • 9. Further study of the anti-inflammatory mode of action of p-butoxyphenylacethydroxamic acid (CP 1044 J3) in the rat.
    Lambelin G; Roba J; Parmentier R; Buu-Hoï NP
    Arch Int Pharmacodyn Ther; 1969 Jul; 180(1):241-53. PubMed ID: 5357009
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-inflammatory activities and mechanisms of action of the petroleum ether fraction of Rosa multiflora Thunb. hips.
    Guo D; Xu L; Cao X; Guo Y; Ye Y; Chan CO; Mok DK; Yu Z; Chen S
    J Ethnopharmacol; 2011 Dec; 138(3):717-22. PubMed ID: 22019508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic efficacy of bufexamac in rheumatoid arthritis: a double-blind comparison with indomethacin.
    Pavelka K; Wagenhauser F
    Curr Ther Res Clin Exp; 1970 Feb; 12(2):69-72. PubMed ID: 4984321
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of bufexamac for rheumatoid arthritis.
    Rose BS; Isdale IC; Conlon PW
    Curr Ther Res Clin Exp; 1970 Mar; 12(3):150-3. PubMed ID: 4985493
    [No Abstract]   [Full Text] [Related]  

  • 13. MF498 [N-{[4-(5,9-Diethoxy-6-oxo-6,8-dihydro-7H-pyrrolo[3,4-g]quinolin-7-yl)-3-methylbenzyl]sulfonyl}-2-(2-methoxyphenyl)acetamide], a selective E prostanoid receptor 4 antagonist, relieves joint inflammation and pain in rodent models of rheumatoid and osteoarthritis.
    Clark P; Rowland SE; Denis D; Mathieu MC; Stocco R; Poirier H; Burch J; Han Y; Audoly L; Therien AG; Xu D
    J Pharmacol Exp Ther; 2008 May; 325(2):425-34. PubMed ID: 18287210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-inflammatory action of an s-triazine derivative in rats.
    Kambayashi Y; Mizushima Y
    Arzneimittelforschung; 1975 Feb; 25(2):230-1. PubMed ID: 1173037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical experiences with a new non-steroid antirheumatic agent].
    Carcassi A
    Minerva Med; 1973; 64(45):2361-4. PubMed ID: 4733891
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-inflammatory activity of Semecarpus anacardium Linn. A preliminary study.
    Satyavati GV; Prasad DN; Das PK; Singh HD
    Indian J Physiol Pharmacol; 1969 Jan; 13(1):37-45. PubMed ID: 4982025
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of anti-inflammatory potential of Chloranthus erectus (Buch.-Ham.) Verd. leaf extract in rats.
    Tag H; Namsa ND; Das AK; Kalita P; Mandal SC
    J Ethnopharmacol; 2009 Nov; 126(2):371-4. PubMed ID: 19703538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-inflammatory effects of leaf and twig of Tripterygium wilfordii on paw edema in mice.
    Yu L; Ao M; Wan J; Zhang Y
    Fitoterapia; 2008 Dec; 79(7-8):529-32. PubMed ID: 18672035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoxicam.
    Downie WW; Gluckman MI; Ziehmer BA; Boyle JA
    Clin Rheum Dis; 1984 Aug; 10(2):385-99. PubMed ID: 6391795
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experimentation and clinical evaluation of ibuprofen, a new synthetic non-steroid antirheumatic agent].
    Perpignano G
    Minerva Med; 1973 Jun; 64(47):2471-4. PubMed ID: 4579838
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.